Genomics Market 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026

Your avatar
IR
Industry Research Report

According to IMARC Group’s latest report, titled “Genomics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global genomics market reached a strong growth in 2020. Looking forward, the market is expected to grow at a CAGR of around 16% during 2021-2026.
 

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
 

Genomics refers to the study of the function, structure, and inheritance of the genome of an organism. It addresses the intrarelationship of all genes for identifying their combined influence on the overall development. It involves several systems, consumables, software and services for the diagnosis, drug discovery, and development of precision medicine. Some of the technologies utilized for genomics include nucleic acid extraction, polymerase chain reaction (PCR) and single-cell genomics analysis.
 

Get Sample Report with Detail COVID-19 Impact Analysis -
https://www.imarcgroup.com/genomics-market/requestsample
 

Market Trends:

The increasing prevalence of chronic diseases represents one of the key factors strengthening the growth of the market. Besides this, genomic data is widely used to produce targeted and personalized medicines and study the growth of military genomics across clinical workflows. This, in confluence with an increasing utilization of genetically modified (GM) plants and organisms in the agriculture sector, is propelling the market growth. Furthermore, technological advancements like the introduction of genomics-based tests and apps and extensive research and development (R&D) activities in the field of bioinformatics are also supporting the market growth.

 

Buy Full Report with Detail Analysis with COVID-19 Impact – https://www.imarcgroup.com/genomics-market
 

List of Key Companies Covered in this Market Report:

23andMe Inc.

Agilent Technologies Inc.

Bayer Aktiengesellschaft

BGI Genomics Co. Ltd.

Bio-RAD Laboratories Inc.

Danaher Corporation

Illumina Inc.

Oxford Nanopore Technologies

PerkinElmer Inc.

Myriad Genetics Inc.

Roche Holding AG

Thermo Fisher Scientific Inc.
 

Breakup by Component:

Products

Instruments and Software

Consumables and Reagents

Services

Core Genomics Services

NGS-Based Services

Biomarker Translation Services

Computational Services

Others
 

Breakup by Application:

Functional Genomics

Epigenomics

Biomarkers Discovery

Pathway Analysis

Others
 

Breakup by Technology:

Sequencing

Microarray

Polymerase Chain Reaction

Nucleic Acid Extraction and Purification

Others
 

Breakup by End-User:

Research Centers

Hospitals and Clinics

Pharmaceutical and Biotechnology Companies

Others
 

Breakup by Geography:

North America (U.S. & Canada)

Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)

Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)

Latin America (Brazil, Mexico)

Middle East & Africa
 

Key highlights of the report:

Market Performance (2015-2020)

Market Outlook (2021- 2026)

Porter’s Five Forces Analysis

Market Drivers and Success Factors

SWOT Analysis

Value Chain

Comprehensive Mapping of the Competitive Landscape
 

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
 

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
 

Contact US:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Keep discovering on Mamby:

If you liked this post, you may also be interested in...
O
Information Work with us Contact Terms and Conditions FAQs
© 2021, Mamby Investments